111 Where an application describes a nucleotide or amino acid sequence other than a sequence identified as forming part of the prior art,
(a) the description shall contain in respect of that sequence, a sequence listing;
(b) a copy of the sequence listing shall be filed in a computer-readable form that complies with section 131; and
(c) a statement shall be filed by the applicant with the Commissioner that the content of the copy of the sequence listing in computer-readable form is the same as the content of the sequence listing contained in the description.
- Date modified: